Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burdenJulia Femel(Miltenyi Biotec (Germany)), Anna‐Karin Olsson(Uppsala University)Cancer Immunology ImmunotherapyJanuary 11, 202210.1007/s00262-021-03139-4Cited by 1SaveCiteExport RISWatch citationsRelated PapersEvolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma|Cancer Cell|2021|154Platelet-Derived PDGFB Promotes Recruitment of Cancer-Associated Fibroblasts, Deposition of Extracellular Matrix and Tgfβ Signaling in the Tumor Microenvironment|Cancers|2022|51Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously|The FASEB Journal|2016|14